Global Cancer Immunotherapy Drug Discovery Outsourcing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

Description

List of Tables

Value Market Research deeply researched the Global Cancer Immunotherapy Drug Discovery Outsourcing Market to foresee a significant growth in the industry over the upcoming years. The global cancer immunotherapy drug discovery outsourcing market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global cancer immunotherapy drug discovery outsourcing market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this cancer immunotherapy drug discovery outsourcing market.

The next sections of the cancer immunotherapy drug discovery outsourcing market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America: United States, Canada, and Mexico

Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC

Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Drug Type

Monoclonal Antibodies
Immunomodulators
Oncolytic Viral Therapies And Cancer Vaccines
Others

By Service Type

Target Identification And Validation
Lead Screening And Characterization
Cell Based Assays

By Cancer Type

Lung
Breast
Colorectal
Melanoma
Prostate
Head And Neck
Ovarian
Pancreatic

Product Code: VMR11211227

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Cancer Immunotherapy Drug Discovery Outsourcing Market
2.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot

3 . CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING - INDUSTRY ANALYSIS

3.1. Introduction
3.2. Market Drivers of Cancer Immunotherapy Drug Discovery Outsourcing Market
3.3. Market Restraints of Cancer Immunotherapy Drug Discovery Outsourcing Market
3.4. Opportunities of Cancer Immunotherapy Drug Discovery Outsourcing Market
3.5. Trends of Cancer Immunotherapy Drug Discovery Outsourcing Market
3.6. Porter's Five Force Analysis of Cancer Immunotherapy Drug Discovery Outsourcing Market
3.7. Cancer Immunotherapy Drug Discovery Outsourcing Market Attractiveness Analysis
- 3.7.1 Market Attractive Analysis by Drug Type
- 3.7.2 Market Attractive Analysis by Service Type
- 3.7.3 Market Attractive Analysis by Cancer Type
- 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

4.1. Cancer Immunotherapy Drug Discovery Outsourcing Value Chain Analysis
4.2. Cancer Immunotherapy Drug Discovery Outsourcing Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Cancer Immunotherapy Drug Discovery Outsourcing Raw Material Manufactures List
- 4.2.3. Price Trend of Cancer Immunotherapy Drug Discovery Outsourcing Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY DRUG TYPE

5.1 Overview by Drug Type
5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type
5.3 Market Analysis of Monoclonal Antibodies by Regions
5.4 Market Analysis of Immunomodulators by Regions
5.5 Market Analysis of Oncolytic Viral Therapies And Cancer Vaccines by Regions
5.6 Market Analysis of Others by Regions

6 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY SERVICE TYPE

6.1 Overview by Service Type
6.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type
6.3 Market Analysis of Target Identification And Validation by Regions
6.4 Market Analysis of Lead Screening And Characterization by Regions
6.5 Market Analysis of Cell Based Assays by Regions

7 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY CANCER TYPE

7.1 Overview by Cancer Type
7.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type
7.3 Market Analysis of Lung by Regions
7.4 Market Analysis of Breast by Regions
7.5 Market Analysis of Colorectal by Regions
7.6 Market Analysis of Melanoma by Regions
7.7 Market Analysis of Prostate by Regions
7.8 Market Analysis of Head And Neck by Regions
7.9 Market Analysis of Ovarian by Regions
7.10. Market Analysis of Pancreatic by Regions

8 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America
- 8.3.1. Overview
- 8.3.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
- 8.3.3. United State
- 8.3.4. Rest of North America
8.4. Europe
- 8.4.1. Overview
- 8.4.2. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
- 8.4.3. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
- 8.4.4. United Kingdom
- 8.4.5. France
- 8.4.6. Germany
- 8.4.7 Rest of Europe
8.5. Asia Pacific
- 8.5.1. Overview
- 8.5.2. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
- 8.5.3. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
- 8.5.4. China
- 8.5.5. Japan
- 8.5.6. India
- 8.5.7. Rest of Asia Pacific
8.6. Latin America
- 8.6.1. Overview
- 8.6.2. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
- 8.6.3. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
- 8.6.4. Brazil
- 8.6.5. Rest of Latin America
8.7. Middle East & Africa
- 8.7.1. Overview
- 8.7.2. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
- 8.7.3. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
- 8.7.4. Middle East
- 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING COMPANIES

9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Aquila BioMedical
- 10.3.1. Company Overview
- 10.3.2. Financials
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. BPS Bioscience, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financials
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Celentyx Ltd.
- 10.5.1. Company Overview
- 10.5.2. Financials
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Covance, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financials
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Crown Bioscience, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financials
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. DiscoverX Corporation
- 10.8.1. Company Overview
- 10.8.2. Financials
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Explicyte
- 10.9.1. Company Overview
- 10.9.2. Financials
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Genscript Biotech Corporation
- 10.10.1. Company Overview
- 10.10.2. Financials
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. HD Biosciences Co., Ltd.
- 10.11.1. Company Overview
- 10.11.2. Financials
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Horizon Discovery Group PLC
- 10.12.1. Company Overview
- 10.12.2. Financials
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. ImmunXperts SA
- 10.13.1. Company Overview
- 10.13.2. Financials
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Molecular Imaging, Inc.
- 10.14.1. Company Overview
- 10.14.2. Financials
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. Personalis, Inc.
- 10.15.1. Company Overview
- 10.15.2. Financials
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. Promega Corporation
- 10.16.1. Company Overview
- 10.16.2. Financials
- 10.16.3. Products
- 10.16.4. Recent Developments
10.17. STC Biologics
- 10.17.1. Company Overview
- 10.17.2. Financials
- 10.17.3. Products
- 10.17.4. Recent Developments

11. IMPACT ANALYSIS OF COVID-19 OUTBREAK

11.1. Impact Analysis of Covid-19 Outbreak on the Market
- 11.1.1. Direct Impact on Production
- 11.1.2. Supply Chain and Market Disruption
- 11.1.3. Financial Impact on Firms and Financial Markets
11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
11.3. Pre V/S Post COVID-19 Market
11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
11.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies